Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 2/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 5/20 | 0.35 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 5/20 | 0.33 |
| ▸ | MELK | Q14680 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30727682 | 0.84 | PIK3CD (0.39) | PIK3CDPIK3CA | |
| SCHEMBL30727569 | 0.80 | PRKCQ (0.33) | PIK3CDPIK3CASRCPRKCQENPP1 | |
| SCHEMBL30727745 | 0.73 | KRAS (0.37) | PIK3CDPIK3CA | |
| SCHEMBL30727670 | 0.73 | PDE10A (0.34) | PIK3CD | |
| SCHEMBL30727733 | 0.71 | PDE10A (0.37) | — | |
| SCHEMBL30727741 | 0.70 | PRKCQ (0.36) | PIK3CASRCPRKCQPRKCD | |
| SCHEMBL30727729 | 0.69 | KIT (0.36) | — | |
| SCHEMBL30727695 | 0.69 | PIK3CD (0.38) | PIK3CDPIK3CA | |
| SCHEMBL30727739 | 0.68 | PIK3CA (0.41) | PIK3CDPIK3CA | |
| SCHEMBL30727676 | 0.68 | PLAU (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532495-A1 | CD73 INHIBITOR COMPOUNDS | Adorx therapeutics Limited (GB) | 2025-04-09 | — | — | EP | disclosed |
| CN-119585273-A | CD73 inhibitor compounds | 阿道尔克斯治疗有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2023233130-A1 | CD73 INHIBITOR COMPOUNDS | AdoRx Therapeutics Limited (GB) | 2023-12-07 | — | — | WO | disclosed |